125 related articles for article (PubMed ID: 37843009)
1. Orally Administered Silicon Hydrogen Nanomaterials as Target Therapy to Treat Intestinal Diseases.
Wei K; Gong F; Wu J; Tang W; Liao F; Han Z; Pei Z; Lei H; Wang L; Shao M; Liu Z; Cheng L
ACS Nano; 2023 Nov; 17(21):21539-21552. PubMed ID: 37843009
[TBL] [Abstract][Full Text] [Related]
2. Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis.
Hou L; Gong F; Liu B; Yang X; Chen L; Li G; Gong Y; Liang C; Yang N; Shen X; Liu Z; Cheng L
Theranostics; 2022; 12(8):3834-3846. PubMed ID: 35664066
[No Abstract] [Full Text] [Related]
3. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
[TBL] [Abstract][Full Text] [Related]
4. An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis.
Zhang X; Yuan Z; Wu J; He Y; Lu G; Zhang D; Zhao Y; Wu R; Lv Y; Cai K; He S
ACS Nano; 2023 Nov; 17(21):21116-21133. PubMed ID: 37843108
[TBL] [Abstract][Full Text] [Related]
5. Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis.
Min DK; Kim YE; Kim MK; Choi SW; Park N; Kim J
ACS Nano; 2023 Dec; 17(23):24404-24416. PubMed ID: 38039189
[TBL] [Abstract][Full Text] [Related]
6. Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment.
Li R; Fan Y; Liu L; Ma H; Gong D; Miao Z; Wang H; Zha Z
ACS Nano; 2022 Sep; 16(9):15026-15041. PubMed ID: 36037406
[TBL] [Abstract][Full Text] [Related]
7. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy.
Xu C; Chen S; Chen C; Ming Y; Du J; Mu J; Luo F; Huang D; Wang N; Lin Z; Weng Z
Int J Pharm; 2022 Jul; 623():121884. PubMed ID: 35661797
[TBL] [Abstract][Full Text] [Related]
8. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease.
Zhao J; Gao W; Cai X; Xu J; Zou D; Li Z; Hu B; Zheng Y
Theranostics; 2019; 9(10):2843-2855. PubMed ID: 31244927
[TBL] [Abstract][Full Text] [Related]
9. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional two-dimensional Bi
Zhang C; Li Q; Shan J; Xing J; Liu X; Ma Y; Qian H; Chen X; Wang X; Wu LM; Yu Y
Acta Biomater; 2023 Apr; 160():252-264. PubMed ID: 36805534
[TBL] [Abstract][Full Text] [Related]
11. Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease.
Liang X; Wen K; Chen Y; Fang G; Yang S; Li Q
Int J Nanomedicine; 2022; 17():4843-4860. PubMed ID: 36262191
[TBL] [Abstract][Full Text] [Related]
12. Aronia melanocarpa (Michx.) Elliott. attenuates dextran sulfate sodium-induced Inflammatory Bowel Disease via regulation of inflammation-related signaling pathways and modulation of the gut microbiota.
Li Y; Nguepi Tsopmejio IS; Diao Z; Xiao H; Wang X; Jin Z; Song H
J Ethnopharmacol; 2022 Jun; 292():115190. PubMed ID: 35306040
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram with Cu
Zhou W; Zhang H; Huang L; Sun C; Yue Y; Cao X; Jia H; Wang C; Gao Y
Theranostics; 2023; 13(9):2879-2895. PubMed ID: 37284442
[No Abstract] [Full Text] [Related]
14. Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice.
Zhu S; Jiang X; Boudreau MD; Feng G; Miao Y; Dong S; Wu H; Zeng M; Yin JJ
J Nanobiotechnology; 2018 Nov; 16(1):86. PubMed ID: 30384844
[TBL] [Abstract][Full Text] [Related]
15. Broad-Spectrum Reactive Oxygen Species Scavenging and Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease.
Li J; Qiu H; Gong H; Tong W
Biomacromolecules; 2021 Jul; 22(7):3107-3118. PubMed ID: 34160209
[TBL] [Abstract][Full Text] [Related]
16. Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy.
Ma X; Gong H; Liu Y; Liu Y; Ogino K; Xing R; Yan X
J Colloid Interface Sci; 2022 Nov; 626():156-166. PubMed ID: 35780549
[TBL] [Abstract][Full Text] [Related]
17. Capsulated Cellular Nanosponges for the Treatment of Experimental Inflammatory Bowel Disease.
Duan Y; Zhang E; Fang RH; Gao W; Zhang L
ACS Nano; 2023 Aug; 17(16):15893-15904. PubMed ID: 37565604
[TBL] [Abstract][Full Text] [Related]
18. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
[TBL] [Abstract][Full Text] [Related]
19. Regulating the Imbalance of Gut Microbiota by
Xu M; Xue H; Qiao G; Liao M; Kong L; Zhang Q; Lin L; Yang L; Zheng G
Am J Chin Med; 2022; 50(2):553-568. PubMed ID: 35114911
[No Abstract] [Full Text] [Related]
20.
Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
